Clinical Overview
Zotepine is an atypical antipsychotic primarily available in Asian and some European markets, indicated for schizophrenia and other psychotic disorders. It has a complex receptor profile including dopamine, serotonin, and norepinephrine reuptake inhibition, giving it both antipsychotic and potential antidepressant properties.
Primary Clinical Applications
Zotepine is indicated for schizophrenia and may be particularly useful for patients with concurrent depressive symptoms due to its norepinephrine reuptake inhibition. It has demonstrated efficacy for both positive and negative symptoms of schizophrenia and may have mood-stabilizing properties.
Mechanism and Clinical Benefits
Zotepine blocks dopamine D1 and D2 receptors, serotonin 5-HT2A and 5-HT2C receptors, and also inhibits norepinephrine reuptake. This unique combination provides antipsychotic effects while potentially offering antidepressant benefits. The norepinephrine reuptake inhibition may help with negative symptoms and concurrent depression.
Clinical Considerations
Zotepine has a relatively favorable side effect profile compared to typical antipsychotics but can cause sedation, weight gain, and metabolic effects. The norepinephrine reuptake inhibition may provide benefits for patients with schizophrenia and comorbid depression, but also requires monitoring for potential activation or cardiovascular effects. The medication is not widely available in Western markets.
Prescribing Information
Dosing & Administration
Schizophrenia – Adults:
- Initial: 25 mg twice daily
- Titration: Increase by 25-50 mg every few days
- Range: 75-300 mg daily in divided doses
- Maximum: 300 mg daily
Elderly:
- Initial: 12.5-25 mg daily
- Titrate slowly based on response and tolerance
- Maximum: Usually 150 mg daily
Administration:
- Divide daily dose into 2-3 administrations
- Take with food to reduce GI upset
- Largest portion may be given at bedtime
Indications
- Treatment of schizophrenia
- Treatment of other psychotic disorders
- May be particularly useful for patients with concurrent depressive symptoms
Contraindications
- Hypersensitivity to zotepine
- Severe cardiovascular disease
- Acute alcohol or drug intoxication
- Comatose states
Warnings & Precautions
- Seizure risk: Dose-related, particularly at higher doses
- Cardiovascular effects: Monitor blood pressure and heart rate
- Metabolic effects: Monitor weight, glucose, and lipids
- Neuroleptic malignant syndrome: Rare but serious risk
- Tardive dyskinesia: Risk with long-term use
- QT prolongation: Monitor ECG in predisposed patients
Drug Interactions
- CNS depressants: Enhanced sedation
- Antihypertensives: Enhanced hypotensive effects
- Drugs lowering seizure threshold: Increased seizure risk
- CYP1A2 inhibitors: May increase zotepine levels
- QT-prolonging drugs: Additive cardiac effects
Adverse Reactions
Common (>10%):
- Sedation, dizziness, constipation, dry mouth
- Weight gain, increased appetite
Cardiovascular:
- Orthostatic hypotension, tachycardia
Metabolic:
- Weight gain, hyperglycemia, dyslipidemia
Serious:
- Seizures (dose-related), neuroleptic malignant syndrome
- QT prolongation, tardive dyskinesia
Special Populations
- Seizure history: Use with extreme caution, consider alternative
- Cardiovascular disease: Monitor closely for hypotension and arrhythmias
- Diabetes: Monitor glucose levels closely
- Elderly: Start with lower doses, increased risk of sedation and falls
- Pregnancy: Category C – use only if benefits outweigh risks
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
